Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients
Author
Funnell, S. G.P.Dowling, W. E.
Muñoz-Fontela, C.
Gsell, P. S.
Ingber, D. E.
Hamilton, G. A.
Delang, L.
Rocha-Pereira, J.
Kaptein, S.
Dallmeier, K. H.
Neyts, J.
Rosenke, K.
de Wit, E.
Feldmann, H.
Maisonnasse, P.
Le Grand, R.
Frieman, M. B.
Coleman, C. M.
Date
2020-12-01Journal
Nature CommunicationsPublisher
Springer NatureType
Article
Metadata
Show full item recordSponsors
Horizon 2020 Framework ProgrammeIdentifier to cite or link to this item
http://hdl.handle.net/10713/13675ae974a485f413a2113503eed53cd6c53
10.1038/s41467-020-17907-w